Legend Biotech Corp ADR LEGN
News
Legend Biotech Shares Fall After CEO Huang Resigns
Legend Biotech CEO Ying Huang Resigns
Stocks to Watch: Smith & Wesson, Logistic Properties of the Americas, Legend Biotech
Legend Biotech ADSs Fall After Company Announces Public Offering
Legend Biotech ADRs Climb on Preliminary Study Results for Non-Hodgkin Lymphoma Treatment
Legend Biotech Down Over 14%, on Track for Record Low Close — Data Talk
